Loading…
NRC Health is projected to rise to $23.22 by 2027, a +19% move from its current price of $19.51. NRC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $18.96 | $19.52 | $20.11 | +0.07% |
| Aug 4 | $18.74 | $19.54 | $20.37 | +0.15% |
| Aug 5 | $18.58 | $19.55 | $20.57 | +0.22% |
| Aug 6 | $18.45 | $19.57 | $20.75 | +0.29% |
| Aug 7 | $18.34 | $19.58 | $20.91 | +0.37% |
| Aug 8 | $18.23 | $19.60 | $21.06 | +0.44% |
| Aug 9 | $18.14 | $19.61 | $21.20 | +0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.14 | $19.61 | $21.20 | +0.52% |
| Week 2 | $17.66 | $19.71 | $22.00 | +1.03% |
| Week 3 | $17.32 | $19.81 | $22.67 | +1.55% |
| Week 4 | $17.05 | $19.92 | $23.27 | +2.08% |
| Week 5 | $16.82 | $20.02 | $23.82 | +2.60% |
| Week 6 | $16.63 | $20.12 | $24.35 | +3.13% |
| Week 7 | $16.46 | $20.22 | $24.85 | +3.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based set of services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross- continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; and employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; as well as consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage.
In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026.
The company was founded in 1981 and is headquartered in Lincoln, Nebraska.
NRC Health is a healthcare analytics and experience management company with a market cap of $412.42M and a current price of $18.30. It ranks 3182 in market position. The latest price outlook shows upside potential, with year-by-year forecasts indicating growth from 2027 onward and substantial longer-term upside through 2050.
A major floor 19.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.2% below — buyers have tended to step in here.
The nearest ceiling, 16.7% above — a clean break opens room to run.
A major ceiling 26.4% above — clearing it would confirm fresh momentum.
Key NRC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NRC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $20.07 | Sell | $19.82 | Sell |
| MA 10 | $20.67 | Sell | $20.40 | Sell |
| MA 20 | $21.32 | Sell | $20.76 | Sell |
| MA 50 | $20.39 | Sell | $20.29 | Sell |
| MA 100 | $18.96 | Buy | $19.29 | Buy |
| MA 200 | $17.58 | Buy | $18.21 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.73 | Neutral |
| Stoch RSI (14) | 31.37 | Neutral |
| CCI (20) | -149.75 | Sell |
| Williams %R (14) | -70.05 | Info |
| MACD (12,26,9) | -0.38 | Sell |
| ROC (12) | -9.93 | Sell |
| Bollinger %B (20,2) | 0.10 | Neutral |
| Stochastic %K (14) | 29.95 | Neutral |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | -0.75 | Sell |
| Ultimate (7,14,28) | 38.42 | Neutral |
| Momentum (10) | -2.27 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 18.91 | Buy |
| ADX (14) | 17.14 | Neutral |
| ATR (14) | 0.65 | Info |
Technical picture to watch over the next 30 days shows bullish sentiment with a current RSI14 of 30. The SMA50 sits at $20.37 and the SMA200 at $17.51, providing near-term directional cues. Support is set at $17.75 and resistance at $22.77, with a 30-day price range of $15.04 to $22.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.03 | $19.51 | $26.28 | 0% | Neutral | |
| $18.39 | $23.22 | $31.07 | +19% | Neutral | |
| $24.71 | $32.17 | $44.81 | +65% | Bullish | |
| $29.58 | $39.50 | $56.77 | +102% | Bullish | |
| $30.61 | $41.81 | $61.67 | +114% | Bullish | |
| $34.12 | $47.56 | $71.77 | +144% | Bullish | |
| $34.48 | $48.99 | $75.43 | +151% | Bullish | |
| $36.58 | $52.91 | $82.97 | +171% | Bullish | |
| $43.78 | $64.40 | $102.71 | +230% | Bullish | |
| $48.23 | $72.11 | $116.82 | +270% | Bullish | |
| $66.07 | $106.39 | $183.96 | +445% | Bullish | |
| $143.28 | $262.41 | $498.73 | +12.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $12.03 | $19.51 | $23.90 | +0.00% |
| September 2026 | $16.81 | $19.94 | $24.35 | +2.20% |
| October 2026 | $17.46 | $20.86 | $25.77 | +4.63% |
| November 2026 | $17.86 | $21.46 | $26.75 | +2.85% |
| December 2026 | $17.31 | $20.91 | $26.28 | -2.55% |
Click any year to see its month-by-month NRC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NRC could reach as high as $26.28, with a base case around $19.51 and support toward $12.03 — roughly 0% from $19.51. Price action looks broadly range-bound.
Expect NRC to range from $18.39 to $31.07 through 2027. The $23.22 average target implies a +19% move from current prices. That is up +19% on the projected 2026 average. A consolidation phase looks the most probable path here.
The NRC price prediction for 2028 points to an average of $32.17 (low $24.71, high $44.81) — a potential gain of +65% on today's $19.51. Momentum favours further upside here.
In 2029, NRC is projected to trade between $29.58 and $56.77, averaging $39.50 — a potential gain of +102% from today's $19.51. That is up +23% on the projected 2028 average. Buyers look set to stay in control over this stretch.
NRC Health's 2030 outlook centres on $41.81, within a $30.61 to $61.67 range. That is up +6% on the projected 2029 average. That marks a +114% change versus current levels. Momentum favours further upside here.
By 2031, NRC could reach as high as $71.77, with a base case around $47.56 and support toward $34.12 — roughly +144% from $19.51. Buyers look set to stay in control over this stretch.
Expect NRC to range from $34.48 to $75.43 through 2032. The $48.99 average target implies a +151% move from current prices. That is up +3% on the projected 2031 average. Momentum favours further upside here.
The NRC price prediction for 2033 points to an average of $52.91 (low $36.58, high $82.97) — a potential gain of +171% on today's $19.51. Buyers look set to stay in control over this stretch.
In 2034, NRC is projected to trade between $43.78 and $102.71, averaging $64.40 — a potential gain of +230% from today's $19.51. That is up +22% on the projected 2033 average. Momentum favours further upside here.
NRC Health's 2035 outlook centres on $72.11, within a $48.23 to $116.82 range. That is up +12% on the projected 2034 average. That marks a +270% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NRC could reach as high as $183.96, with a base case around $106.39 and support toward $66.07 — roughly +445% from $19.51. Momentum favours further upside here.
Expect NRC to range from $143.28 to $498.73 through 2050. The $262.41 average target implies a +12.5x move from current prices. That is up +147% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NRC today (≈ 51.255766 NRC) could be worth
$13,450.11
+$12,450.11 (+1245%) by 2050 · US Dollar
Based on the average projected NRC price of $262.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NRCwould be worth at today's price.
$1,000 invested in NRC on Jul 31, 2025 (≈ 80 NRC) would be worth
$1,560.8
+$560.8 (+56.1%) today · 1.56× · US Dollar
Based on a NRC entry price of $12.5 vs. today's $19.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.04 | $927.28 | -7.3% |
| 1 month ago | $22.34 | $873.32 | -12.7% |
| 3 months ago | $17.41 | $1,120.62 | +12.1% |
| 6 months ago | $21.9 | $890.87 | -10.9% |
| 1 year ago | $12.5 | $1,560.8 | +56.1% |
| All time (5.0y) ago | $53.51 | $364.6 | -63.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NRC forecast.
Our base-case forecast reaches $39.00 around 2029.
Implied market cap at $39.00: $863.43M
The multi-year forecast outlines a path of rising averages and robust upside. The 2026 forecast shows an average of $18.30 with a neutral sentiment and 0% ROI. From 2027 onward, the averages are expected to rise to $21.21 (ROI 15.9%), $28.92 (ROI 58%), and $35.25 (ROI 92.6%), reaching $37.05 in 2030 (ROI 102.5%) with a bullish sentiment.
By 2031–2035 the average prices advance to $41.66, $42.48, $45.50, $54.56, and $60.58 respectively, with rising ROIs up to 231.1% by 2035. The forecast projects continued strength into 2040 with an average of $87.89 and a max of $152.62 (ROI 380.3%), and into 2050 with an average of $211.80 and a max of $404.56 (ROI 1057.4%), all tagged as bullish. These figures imply substantial upside potential, though they are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $37.05; min $27.06; max $54.81; ROI 102.5%; sentiment BULLISH.
Forecasts show rising averages and positive ROIs from 2027 onward, with 2027 Avg $21.21, 2028 Avg $28.92, 2029 Avg $35.25, 2030 Avg $37.05, 2040 Avg $87.89, and 2050 Avg $211.80; ROIs reach 1057.4% by 2050, with bullish sentiment from 2028 onward.
Yes. The 2040 max is $152.62 and the 2050 max is $404.56, indicating potential to exceed $100 by 2050 according to the forecast.
Current price $18.30; market cap $412.42M.
Avg $28.92; min $22.17; max $40.38; ROI 58%; sentiment BULLISH.
NRC Health Community Discussion
0Share your NRC Health price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.